EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy

Meltem Kumaş iD, Dilek Canlar Akar, Mehmet Gül, Erkan Karadaş, Selen Kum Özşengezer, Kadri Kulualp, Orhan Yavuz, Osman Yilmaz

The FASEB Journal · 15.09.2026 · 40 (17)

DOI: 10.1096/fj.202602487r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 05.09.2026. Verfasst von Meltem Kumaş und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Veterinary Medicine, Dokuz Eylul University, Izmir, Turkey. Hauptthemen laut MEDLINE: Podocytes, Glomerulonephritis, IGA, Spirostans, Kidney. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dokuz Eylül Üniversitesi (DEÜ).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgA nephropathy (IgAN) is a progressive glomerular disease marked by mesangial IgA deposition, inflammation, podocyte injury, and fibrogenesis. Although understanding of its pathophysiology has advanced, effective disease‐modifying therapies are still limited. Sarsasapogenin (SAR), a natural steroidal sapogenin, demonstrates anti‐inflammatory, antioxidant, and antifibrotic properties by modulating signaling pathways such as NF‐κB and TGF‐β. The present study investigated the renoprotective effects of SAR in an experimental model of IgAN. IgAN was induced in Sprague–Dawley rats using bovine serum albumin (BSA), carbon tetrachloride (CCl 4 ), and lipopolysaccharide (LPS). SAR was administered at 60 mg/kg/day from week 7 through week 12. Renal function, histopathological changes (Oxford MEST‐C classification), and immunohistochemical, ultrastructural, and molecular alterations were assessed. Induction of IgAN resulted in significant proteinuria, renal dysfunction, mesangial IgA deposition, and podocyte alterations, accompanied by increased expression of IL‐6, TGF‐β1, SMAD3, fibronectin, and α‐SMA. Masson's trichrome staining did not reveal excessive collagen deposition, indicating early fibrogenic activity rather than established fibrosis. SAR treatment significantly reduced proteinuria and improved renal function, accompanied by decreased IL‐6‐mediated inflammation and reduced activation of the TGF‐β1/SMAD3 pathway. SAR also preserved podocyte‐associated proteins, including nephrin and podocin, and lowered pre‐fibrotic markers. Ultrastructural analysis confirmed preservation of podocyte architecture, with reduced foot process fusion and mesangial matrix expansion. Overall, sarsasapogenin modulated multiple targets in experimental IgAN by reducing inflammation and early fibrogenesis while supporting podocyte integrity. These findings indicate that SAR is a promising therapeutic candidate for early IgAN, although further mechanistic and long‐term studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesGlomerulonephritis, IGASpirostansKidneyAnimalsRats, Sprague-DawleyRatsMaleTransforming Growth Factor beta1ProteinuriaFibrosisMembrane ProteinsDisease Models, AnimalSmad3 ProteinIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

IgA nephropathyTGF‐β/SMAD signalingexperimental modelpodocyte injuryrenal fibrosissarsasapogenin

Substanzen

SpirostanssarsasapogeninTransforming Growth Factor beta1Membrane ProteinsSmad3 ProteinIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Histology and Embryology, Faculty of Veterinary Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Department of Biochemistry, Faculty of Veterinary Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Department of Basic Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey.
  • Department of Surgery, Faculty of Veterinary Medicine, Dokuz Eylul University, Izmir, Turkey.

ORCID-Profile: Meltem Kumaş

Förderung

  • Dokuz Eylül Üniversitesi (DEÜ)

Zitieren

APA

Kumaş, M., Canlar Akar, D., Gül, M., Karadaş, E., Kum Özşengezer, S., Kulualp, K., Yavuz, O., & Yilmaz, O. (2026). Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy. The FASEB Journal, 40(17). https://doi.org/10.1096/fj.202602487r

Vancouver

Kumaş M, Canlar Akar D, Gül M, Karadaş E, Kum Özşengezer S, Kulualp K, et al. Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy. The FASEB Journal. 2026;40(17). doi:10.1096/fj.202602487r

BibTeX
@article{Kuma2026,
  author = {Kumaş, Meltem and Canlar Akar, Dilek and Gül, Mehmet and Karadaş, Erkan and Kum Özşengezer, Selen and Kulualp, Kadri and Yavuz, Orhan and Yilmaz, Osman},
  title = {Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {17},
  doi = {10.1096/fj.202602487r}
}
Kostenlos starten →